Investor Tips

Pfizer’s COVID Hangover

Products You May Like

Pfizer is either saviour or satan to many, but even after a huge drop in COVID revenue it is still an attractive stock.

#US #Pharma #Pharmaceutical #COVID #Stocks #Stock Market #Equities #Investing #Trading #PFE #AMGN #JNJ #ABBV #LLY

Products You May Like

Articles You May Like

BlackRock expands its tokenized money market fund to Polygon and other blockchains
The top 10 family offices for startup investments
Here’s why tax-loss harvesting can be easier with exchange-traded funds
Tencent posts better-than-expected 47% profit surge as games, AI tools shine
Home Depot’s sales are improving, but it says consumers are still cautious about spending